Sepsis Clinical Trials

Find Sepsis Clinical Trials Near You

The Effects of a AN69ST Membrane and Polysulphone Membrane on Septic Children With Continuous Blood Purification

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

In septic shock, dysregulated host responses to pathogens lead to cytokine storms that damage host tissues and organs, further contributing to the development of organ dysfunction and increased mortality. For sepsis, blood purification can remove inflammatory factors in sepsis by filtration or adsorption, so as to achieve the purpose of reducing inflammatory mediators in the body. However, there are few prospective randomized controlled studies in children. Therefore, this study intends to compare the efficacy and prognosis of different membrane on children with sepsis through a perspective cohort study, so as to provide a corresponding basis for the treatment of children with sepsis blood purification.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 29 days
Maximum Age: 28
View:

• Meet the 2005 diagnostic criteria for sepsis

• Age 29 days - 18 years old

• Sepsis-induced dysfunction of more than one organ or abnormal tissue perfusion, or septic shock

• Diagnosis \< 48 hours

Locations
Other Locations
China
Children's Hospital of Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Jiayun Ying
jiayundoctor@163.com
18817583962
Backup
Guoping Lu
13788904150@163.com
13788904150
Time Frame
Start Date: 2025-10-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 80
Treatments
blood purification(AN69ST)
blood purification(PS)
Related Therapeutic Areas
Sponsors
Collaborators: Shandong Provincial Hospital, Children's Hospital of Chongqing Medical University, Southern Medical University, China, First Affiliated Hospital of Xinjiang Medical University, West China Second University Hospital, Children's Hospital of Soochow University
Leads: Children's Hospital of Fudan University

This content was sourced from clinicaltrials.gov